share_log

Insider Sale: EVP of $CRCT (CRCT) Sells 30,000 Shares

Quiver Quantitative ·  11/26 13:17

Donald B. Olsen, the EVP of $CRCT ($CRCT), sold 30,000 shares of the company on 11-25-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.6% of their shares. Following this trade, they now own 625,833 shares of $CRCT stock.

$CRCT Insider Trading Activity

$CRCT insiders have traded $CRCT stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here's a breakdown of recent trading of $CRCT stock by insiders over the last 6 months:

  • DONALD B. OLSEN (EVP, General Counsel & Sec.) has traded it 2 times. They made 0 purchases and 2 sales, selling 70,000 shares.
  • ARORA ASHISH (Chief Executive Officer) has traded it 7 times. They made 0 purchases and 7 sales, selling 301,729 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CRCT Hedge Fund Activity

We have seen 68 institutional investors add shares of $CRCT stock to their portfolio, and 69 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • MORGAN STANLEY removed 1,578,055 shares (-77.3%) from their portfolio in Q3 2024
  • AMERICAN CENTURY COMPANIES INC added 492,947 shares (+108.8%) to their portfolio in Q3 2024
  • VANGUARD GROUP INC added 408,309 shares (+9.1%) to their portfolio in Q3 2024
  • AQR CAPITAL MANAGEMENT LLC removed 286,234 shares (-37.4%) from their portfolio in Q3 2024
  • MILLENNIUM MANAGEMENT LLC removed 253,496 shares (-34.9%) from their portfolio in Q3 2024
  • BLACKROCK, INC. added 203,500 shares (+6.2%) to their portfolio in Q3 2024
  • FIRST TRUST ADVISORS LP added 172,908 shares (+inf%) to their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする